These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30366813)

  • 1. AISF position paper on HCV in immunocompromised patients.
    Italian Association for the Study of the Liver (AISF)
    Dig Liver Dis; 2019 Jan; 51(1):10-23. PubMed ID: 30366813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.
    Chute DF; Chung RT; Sise ME
    Kidney Int; 2018 Mar; 93(3):560-567. PubMed ID: 29325996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of recurrent hepatitis C virus after liver transplantation.
    Jiménez-Pérez M; González-Grande R; Rando-Muñoz FJ
    World J Gastroenterol; 2014 Nov; 20(44):16409-17. PubMed ID: 25469009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
    Fabrizi F; Martin P; Messa P
    Kidney Int; 2016 May; 89(5):988-994. PubMed ID: 27083277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Direct-acting antiviral agents, hepatitis C and dialysis: an update].
    Fabrizi F; Lampertico P; Messa P
    G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories.
    Mendizabal M; Reddy KR
    J Viral Hepat; 2017 Jun; 24(6):442-453. PubMed ID: 28107583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.
    Bhamidimarri KR; Ladino M; Pedraza F; Guerra G; Mattiazzi A; Chen L; Ciancio G; Kupin W; Martin P; Burke G; Roth D
    Transpl Int; 2017 Sep; 30(9):865-873. PubMed ID: 28332729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common issues in the management of patients in the waiting list and after liver transplantation.
    Burra P; Belli LS; Ginanni Corradini S; Volpes R; Marzioni M; Giannini E; Toniutto P
    Dig Liver Dis; 2017 Mar; 49(3):241-253. PubMed ID: 28096056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
    Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL;
    Dig Liver Dis; 2018 Nov; 50(11):1133-1152. PubMed ID: 30266305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Hepatitis C Treatment and the Impact on Kidney Transplantation.
    Sawinski D; Bloom RD
    Transplantation; 2015 Dec; 99(12):2458-66. PubMed ID: 26214816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
    Lin MV; Sise ME; Pavlakis M; Amundsen BM; Chute D; Rutherford AE; Chung RT; Curry MP; Hanifi JM; Gabardi S; Chandraker A; Heher EC; Elias N; Riella LV
    PLoS One; 2016; 11(7):e0158431. PubMed ID: 27415632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy.
    Sagnelli E; Stroffolini T; Sagnelli C; Cacopardo B; Andriulli A; Babudieri S; Coppola N; Gaeta GB; Almasio PL
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):676-681. PubMed ID: 29465473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
    Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL; ; ; ;
    Intern Emerg Med; 2018 Dec; 13(8):1139-1166. PubMed ID: 30255464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies.
    Dever JB; Ducom JH; Ma A; Nguyen J; Liu L; Herrin A; Groessl EJ; Ho SB
    Dig Dis Sci; 2017 Jun; 62(6):1472-1479. PubMed ID: 28378246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of hepatitis C virus infection treatment in kidney transplant candidates.
    Cohen-Bucay A; Francis JM; Gordon CE
    Hemodial Int; 2018 Apr; 22 Suppl 1():S61-S70. PubMed ID: 29694723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C and work impairment: a review of current literature.
    Manne V; Sassi K; Allen R; Saab S
    J Clin Gastroenterol; 2014 Aug; 48(7):595-9. PubMed ID: 24492408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and management options for the hepatitis C virus infected kidney transplant candidate.
    Dejman A; Ladino MA; Roth D
    Hemodial Int; 2018 Apr; 22 Suppl 1():S36-S44. PubMed ID: 29694726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral Agents.
    Cholankeril G; Li AA; March KL; Yoo ER; Kim D; Snyder H; Gonzalez SA; Younossi ZM; Ahmed A
    Clin Gastroenterol Hepatol; 2018 Mar; 16(3):452-453. PubMed ID: 28838786
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C.
    Brandhagen DJ; Gross JB; Poterucha JJ; Charlton MR; Detmer J; Kolberg J; Gossard AA; Batts KP; Kim WR; Germer JJ; Wiesner RH; Persing DH
    Am J Gastroenterol; 1999 Apr; 94(4):1000-5. PubMed ID: 10201473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.